1-33036828-T-C

Variant summary

Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong

The NM_001625.4(AK2):​c.1A>G​(p.Met1?) variant causes a start lost change. The variant allele was found at a frequency of 0.00000765 in 1,437,220 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000077 ( 0 hom. )

Consequence

AK2
NM_001625.4 start_lost

Scores

5
8
3

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:4

Conservation

PhyloP100: 3.81

Publications

3 publications found
Variant links:
Genes affected
AK2 (HGNC:362): (adenylate kinase 2) Adenylate kinases are involved in regulating the adenine nucleotide composition within a cell by catalyzing the reversible transfer of phosphate groups among adenine nucleotides. Three isozymes of adenylate kinase, namely 1, 2, and 3, have been identified in vertebrates; this gene encodes isozyme 2. Expression of these isozymes is tissue-specific and developmentally regulated. Isozyme 2 is localized in the mitochondrial intermembrane space and may play a role in apoptosis. Mutations in this gene are the cause of reticular dysgenesis. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 1 and 2.[provided by RefSeq, Nov 2010]
AK2 Gene-Disease associations (from GenCC):
  • reticular dysgenesis
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 14 ACMG points.

PVS1
Start lost variant, next in-frame start position is after 5 pathogenic variants. Next in-frame start position is after 49 codons. Genomic position: 33024516. Lost 0.201 part of the original CDS.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 1-33036828-T-C is Pathogenic according to our data. Variant chr1-33036828-T-C is described in ClinVar as Pathogenic. ClinVar VariationId is 18252.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AK2NM_001625.4 linkc.1A>G p.Met1? start_lost Exon 1 of 6 ENST00000672715.1 NP_001616.1 P54819-1A0A140VK93

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AK2ENST00000672715.1 linkc.1A>G p.Met1? start_lost Exon 1 of 6 NM_001625.4 ENSP00000499935.1 P54819-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000957
AC:
2
AN:
208954
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000328
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000110
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000765
AC:
11
AN:
1437220
Hom.:
0
Cov.:
31
AF XY:
0.00000561
AC XY:
4
AN XY:
712930
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33026
American (AMR)
AF:
0.0000240
AC:
1
AN:
41622
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25634
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38582
South Asian (SAS)
AF:
0.0000241
AC:
2
AN:
83006
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51282
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4154
European-Non Finnish (NFE)
AF:
0.00000727
AC:
8
AN:
1100618
Other (OTH)
AF:
0.00
AC:
0
AN:
59296
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Reticular dysgenesis Pathogenic:3
Dec 02, 2023
Laboratory of Hereditary Immune Disorders, Research Centre for Medical Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The start-loss variant NM_001625.4(AK2):c.1A>G, p.(Met1?) was identified in a homozygous state in a proband diagnosed with reticular dysgenesis in Russian pilot NBS project covering more than 200,000 newborns. This variant has been previously reported in the literature multiple times (PMIDs: 19043417) and is listed in gnomAD v2.1.1 two times in heterozygous individuals. The loss of translation initiation codon should lead to near complete reduction in translation level or synthesis of N-terminally truncated protein (the next ATG-codon located in position Met49. Taken together, the variant meets the following ACMG/AMP criteria and can be classified as pathogenic with PM2, PP3, PVS1, PP5, PP4 criteria. -

Jan 01, 2009
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Feb 01, 2024
Neuberg Centre For Genomic Medicine, NCGM
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The start lost c.1A>G (p.Met1?) variant in AK2 gene has been reported previously in compound heterozygous state in an individual affected with reticular dysgenesis (Pannicke et al., 2009).The p.Met1? variant is predicted to disrupt the initiation codon, and thus potentially may interfere with protein expression -

Severe combined immunodeficiency disease Pathogenic:1
Apr 23, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: AK2 c.1A>G (p.Met1Val) alters the initiation codon and is predicted to result either in absence of the protein or truncation of the encoded protein due to translation initiation at a downstream codon. An alternative downstream in-frame start codon (Met49) is located in the encoded protein. An activation of potential downstream translation initiation site would result in a shortened protein missing the first 48 amino acids from the protein sequence. Two of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 9.6e-06 in 208954 control chromosomes. c.1A>G has been observed as a biallelic genotype in multiple individuals affected with Reticular Dysgenesis (e.g. Pannicke_2009, Guilcher_2017, Marakhonov_2024). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 27913909, 28331055, 38578360, 19043417). ClinVar contains an entry for this variant (Variation ID: 18252). Based on the evidence outlined above, the variant was classified as pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.30
D
BayesDel_noAF
Pathogenic
0.29
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.023
.;.;T;T;.;T;.;T
Eigen
Uncertain
0.33
Eigen_PC
Uncertain
0.33
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.90
D;D;D;D;.;D;D;D
M_CAP
Pathogenic
0.92
D
MetaRNN
Pathogenic
0.99
D;D;D;D;D;D;D;D
MetaSVM
Uncertain
0.32
D
PhyloP100
3.8
PROVEAN
Benign
-0.98
.;N;N;N;N;N;N;.
REVEL
Uncertain
0.56
Sift
Uncertain
0.0030
.;D;D;D;D;D;D;.
Sift4G
Uncertain
0.035
D;D;D;D;D;D;D;D
Polyphen
0.91, 0.95, 0.86
.;P;P;.;.;P;.;.
Vest4
0.92
MutPred
1.0
Loss of glycosylation at P6 (P = 0.2007);Loss of glycosylation at P6 (P = 0.2007);Loss of glycosylation at P6 (P = 0.2007);Loss of glycosylation at P6 (P = 0.2007);Loss of glycosylation at P6 (P = 0.2007);Loss of glycosylation at P6 (P = 0.2007);Loss of glycosylation at P6 (P = 0.2007);Loss of glycosylation at P6 (P = 0.2007);
MVP
0.81
ClinPred
0.94
D
GERP RS
4.9
PromoterAI
-0.19
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.66
gMVP
0.84
Mutation Taster
=1/199
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs137853206; hg19: chr1-33502429; COSMIC: COSV61467031; COSMIC: COSV61467031; API